The aim of this study is to evaluate shed SDC-1 in pleural effusions together with angiogenesis related proteins and identify optimal biomarker batteries that allow earlier diagnosis and improve the possibilities to distinguish MPM from metastatic adenocarcinoma and reactive conditions. This evidence concerns the gene SDC1 and Pleural effusion.